· Co-founder & Partner at MedCI LLC (Santa Clara, CA, USA)

· Business Consultant, Univ. of Michigan Hospital International Patient Center

· Business Consultant, Trinity Health System

· MBA, University of Michigan

· Co-Founder & Partner at MedCI LLC (Santa Clara, CA, USA)

· Practicing in internal medicine at Stanford University Hospital

· Director, Marketing, Xolan Technologies

· MD, University of Texas at San Antonio

· MBA, University of Michigan

· Chief of Business Center, R&D, AprilBio

· Senior Research Scientist, Immuno-Oncology, MOGAM Institute

· Post-Doc, La Jolla Institute for Allergy and Immunology

· PhD, Immunology from University of North Carolina at Chapel Hill

· Director, Research & Development, QuBESTBio / MitoImmune Therapeutics

· Senior Researcher, Life Sciences New Drug Research Center, LG Chem

· MS, Virology from Sogang University

· Head of Business strategy team, YMTECH

· Head of the management planning team,

 Chungcheongnam-do Economic Promotion Agency

· BL , Department of Law from Sungkyunkwan University

· MBA , Chungbuk National University Graduate School of Business

· Biologics CMC consultant

· Specialties in outsourcing/virtual development, contract negotiations, due diligence, supply chain, process development, analytical development, CMC regulatory submissions

· Senior Director, Pfizer

· PhD, Biophysical Chemistry, University of California, Berkeley

· Professor, Department of Civil & Environmental Engineering, University of Michigan

· Research on methanotrophs over 20 years

· Principal investigator and co‐inventor of methanobactin

· Over 100 publications and patents

· PhD, Environmental Engineering Science, California Institute of Technology

· Professor, Department of Biochemistry, Biophysics and Molecular Biology, Iowa State University

· Internationally recognized expert in methanotrophy (physiology/biochemistry)

· Principal investigator and co‐inventor of methanobactin

· Over 125 publications and patents

· PhD, Microbiology, Ohio State University

· Professor, Technical University Munich, Institute for Toxicology and Environmental Hygiene

· Group leader, Helmholtz Zentrum Munchen Molecular Toxicology & Pharmacology

· Over 80 publications and patents

· Investigator of methanobactin for Wilson’s Disease

· PhD, Biochemistry, University of Tubingen